CF PHARMTECH (02652) spent 962,500 Hong Kong dollars to repurchase 27,500 shares on February 13th.
Changfeng Pharmaceutical (02652) announced that it will spend 962,500 Hong Kong dollars to repurchase 27,500 shares on February 13, 2026.
CF PHARMTECH (02652) announced on February 13, 2026, that it will spend 962,500 Hong Kong dollars to repurchase 27,500 shares.
Related Articles
QINGHUA HOLD(08082): Tang Caizhi sells 518 million shares of the company to Liu Xuefeng.
EDDING GENOR (06998) spent approximately HKD 1.859 million on repurchasing 611,500 shares on February 13th.
SUNSHINE INS Group Co., Ltd. reduced its holding of 50 million shares of HUISHANG BANK (03698) at a price of HK$3.49 per share.
QINGHUA HOLD(08082): Tang Caizhi sells 518 million shares of the company to Liu Xuefeng.
EDDING GENOR (06998) spent approximately HKD 1.859 million on repurchasing 611,500 shares on February 13th.
SUNSHINE INS Group Co., Ltd. reduced its holding of 50 million shares of HUISHANG BANK (03698) at a price of HK$3.49 per share.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
